JPY 1741.0
(1.22%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 15.8 Billion JPY | -14.59% |
2022 | 17.14 Billion JPY | -2.03% |
2021 | 17.49 Billion JPY | -6.1% |
2020 | 19.28 Billion JPY | -11.53% |
2019 | 22.73 Billion JPY | -2.01% |
2018 | 23.06 Billion JPY | 2.72% |
2017 | 21.86 Billion JPY | 19.78% |
2016 | 18.37 Billion JPY | 6.45% |
2015 | 17.52 Billion JPY | 14.6% |
2014 | 15.29 Billion JPY | 17.82% |
2013 | 13.1 Billion JPY | 41.34% |
2012 | 9.26 Billion JPY | 35.93% |
2011 | 6.63 Billion JPY | 6.31% |
2010 | 6.35 Billion JPY | -0.73% |
2009 | 6.02 Billion JPY | 3.29% |
2008 | 5.99 Billion JPY | 21.6% |
2007 | 4.77 Billion JPY | 17.86% |
2006 | 5.16 Billion JPY | 9.28% |
2005 | 3.98 Billion JPY | -7.13% |
2004 | 4.29 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 4.34 Billion JPY | 47.79% |
2024 Q1 | 3.92 Billion JPY | 7970.27% |
2023 FY | - JPY | -14.59% |
2023 Q3 | 4.05 Billion JPY | 20.54% |
2023 Q4 | 1.78 Billion JPY | -55.9% |
2023 Q2 | 3.36 Billion JPY | -11.86% |
2023 Q1 | 3.81 Billion JPY | 40.41% |
2022 Q2 | 2.45 Billion JPY | -38.39% |
2022 Q4 | 2.71 Billion JPY | -38.2% |
2022 Q1 | 3.99 Billion JPY | 37.29% |
2022 FY | - JPY | -2.03% |
2022 Q3 | 4.39 Billion JPY | 78.65% |
2021 Q1 | 3.46 Billion JPY | 34.67% |
2021 FY | - JPY | -6.1% |
2021 Q2 | 5.09 Billion JPY | 47.16% |
2021 Q3 | 3.25 Billion JPY | -36.14% |
2021 Q4 | 2.9 Billion JPY | -10.72% |
2020 Q2 | 4.7 Billion JPY | 21.6% |
2020 Q1 | 3.86 Billion JPY | 0.0% |
2020 FY | - JPY | -11.53% |
2020 Q3 | 5 Billion JPY | 6.49% |
2020 Q4 | 2.57 Billion JPY | -48.59% |
2019 Q3 | 4.41 Billion JPY | -14.29% |
2019 Q2 | 5.15 Billion JPY | 15.61% |
2019 Q1 | 4.46 Billion JPY | 64.33% |
2019 FY | - JPY | -2.01% |
2018 Q1 | 5.38 Billion JPY | 8.44% |
2018 Q2 | 6.29 Billion JPY | 17.02% |
2018 Q3 | 6 Billion JPY | -4.65% |
2018 Q4 | 2.71 Billion JPY | -54.8% |
2018 FY | - JPY | 2.72% |
2017 Q3 | 5.79 Billion JPY | 28.06% |
2017 FY | - JPY | 19.78% |
2017 Q2 | 4.52 Billion JPY | -6.99% |
2017 Q4 | 4.96 Billion JPY | -14.3% |
2017 Q1 | 4.86 Billion JPY | 12.83% |
2016 FY | - JPY | 6.45% |
2016 Q4 | 4.3 Billion JPY | -4.41% |
2016 Q3 | 4.5 Billion JPY | 10.82% |
2016 Q2 | 4.06 Billion JPY | 12.47% |
2016 Q1 | 3.61 Billion JPY | -0.5% |
2015 FY | - JPY | 14.6% |
2015 Q1 | 3.68 Billion JPY | 9.43% |
2015 Q2 | 4.23 Billion JPY | 14.85% |
2015 Q4 | 3.63 Billion JPY | 0.55% |
2015 Q3 | 3.61 Billion JPY | -14.55% |
2014 Q3 | 4 Billion JPY | 20.94% |
2014 Q1 | 2.67 Billion JPY | 25.23% |
2014 FY | - JPY | 17.82% |
2014 Q4 | 3.36 Billion JPY | -16.04% |
2014 Q2 | 3.31 Billion JPY | 24.03% |
2013 Q1 | 2.19 Billion JPY | 16.12% |
2013 Q4 | 2.13 Billion JPY | -42.96% |
2013 Q3 | 3.74 Billion JPY | 25.7% |
2013 FY | - JPY | 41.34% |
2013 Q2 | 2.97 Billion JPY | 35.57% |
2012 Q2 | 1.67 Billion JPY | 3.11% |
2012 Q3 | 2.26 Billion JPY | 35.21% |
2012 Q4 | 1.89 Billion JPY | -16.67% |
2012 Q1 | 1.62 Billion JPY | -14.91% |
2012 FY | - JPY | 35.93% |
2011 Q1 | 1.21 Billion JPY | -46.97% |
2011 Q2 | 1.85 Billion JPY | 52.6% |
2011 FY | - JPY | 6.31% |
2011 Q3 | 1.82 Billion JPY | -1.77% |
2011 Q4 | 1.91 Billion JPY | 4.8% |
2010 Q3 | 1.38 Billion JPY | -9.72% |
2010 FY | - JPY | -0.73% |
2010 Q4 | 2.29 Billion JPY | 65.84% |
2010 Q2 | 1.53 Billion JPY | 26.82% |
2010 Q1 | 1.2 Billion JPY | -19.82% |
2009 Q4 | 1.5 Billion JPY | -19.81% |
2009 Q3 | 1.88 Billion JPY | 1.5% |
2009 Q1 | 1.2 Billion JPY | 0.0% |
2009 Q2 | 1.85 Billion JPY | 53.34% |
2009 FY | - JPY | 3.29% |
2008 FY | - JPY | 21.6% |
2007 FY | - JPY | 17.86% |
2006 FY | - JPY | 9.28% |
2005 FY | - JPY | -7.13% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -895.398% |
Euglena Co., Ltd. | 676 Million JPY | -2238.166% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | -704.446% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -2744.044% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -293.87% |
Kao Corporation | 154.49 Billion JPY | 89.769% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -1054.124% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 67.646% |
Shiseido Company, Limited | 106.46 Billion JPY | 85.153% |
Lion Corporation | 42.31 Billion JPY | 62.646% |
Mandom Corporation | 6.69 Billion JPY | -135.946% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -6415.251% |
Milbon Co., Ltd. | 7.8 Billion JPY | -102.63% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -1126.625% |
Fancl Corporation | 16.6 Billion JPY | 4.8% |
KOSÉ Corporation | 26.85 Billion JPY | 41.148% |
Cota Co., Ltd. | 2.26 Billion JPY | -596.77% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 1302.608% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -9097.717% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 31.803% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | -29.092% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -12646.774% |
Almado, Inc. | 983.21 Million JPY | -1507.578% |
I-ne CO., LTD. | 4.7 Billion JPY | -236.298% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 2620.893% |
Liberta Co.,Ltd. | 318.19 Million JPY | -4867.441% |
AXXZIA Inc. | 1.28 Billion JPY | -1128.597% |
S.T. Corporation | 2.62 Billion JPY | -501.904% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 50.114% |
Earth Corporation | 10.6 Billion JPY | -49.001% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -1344.069% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 2853.75% |
Ya-Man Ltd. | 1.43 Billion JPY | -1000.106% |
MTG Co., Ltd. | 4.39 Billion JPY | -259.718% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | -172.083% |
SHOBIDO Corporation | 1.11 Billion JPY | -1323.713% |
Artnature Inc. | 3.78 Billion JPY | -317.375% |
Unicharm Corporation | 178.01 Billion JPY | 91.121% |
Paltac Corporation | 35.92 Billion JPY | 56.0% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -381.157% |